Yang B, Li X, Fu Y, Guo E, et al. MEK Inhibition Remodels the Immune Landscape of Mutant KRAS Tumors to Overcome Resistance to PARP and Immune Checkpoint Inhibitors. Cancer Res 2021;81:2714-2729.
PMID: 33589518